Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.67 |
| ▸ | SERPINE1 | P05121 | 6/20 | 0.64 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.63 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.63 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.63 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | POLA1 | P09884 | 1/20 | 0.61 |
| ▸ | ANTXR2 | P58335 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | TYR | P14679 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17220942 | 0.91 | ESR1 (0.82) | ESR1SERPINE1AKR1C4AKR1C3AKR1C2 | |
| Propyl Gallate SCHEMBL788397 | 0.90 | ESR1 (0.80) | ESR1SERPINE1AKR1C4AKR1C3AKR1C2 | |
| Propyl Gallate SCHEMBL22630 | 0.90 | ESR1 (0.80) | ESR1SERPINE1AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL15453542 | 0.90 | LMNA (0.65) | ESR1SERPINE1AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL17220946 | 0.90 | ESR1 (0.81) | ESR1SERPINE1AKR1C4AKR1C3AKR1C2 | |
| Propyl Gallate SCHEMBL8334443 | 0.89 | ESR1 (0.77) | ESR1SERPINE1AKR1C4AKR1C3AKR1C2 | |
| Propyl Gallate SCHEMBL28626398 | 0.89 | ESR1 (0.77) | ESR1SERPINE1AKR1C4AKR1C3AKR1C2 | |
| Propyl Gallate SCHEMBL29910229 | 0.89 | ESR1 (0.77) | ESR1SERPINE1AKR1C4AKR1C3AKR1C2 | |
| Propyl Gallate SCHEMBL16678445 | 0.89 | ESR1 (0.77) | ESR1SERPINE1AKR1C4AKR1C3AKR1C2 | |
| Propyl Gallate SCHEMBL9389174 | 0.89 | ESR1 (0.77) | ESR1SERPINE1AKR1C4AKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150313925-A1 | COMBINATION OF COMPOUNDS DERIVED FROM GALLIC ACID FOR THE TREATMENT OF CANCER | PONTIFICIA UNIVERSIDAD JAVERIANA (CO) | 2015-11-05 | — | — | US | claimed |
| WO-2013007607-A2 | HAIR CARE COMPOSITION | UNILEVER PLC (GB) | 2013-01-17 | — | — | WO | claimed |
| WO-2013007606-A2 | HAIR CARE COMPOSITION | UNILEVER PLC (GB) | 2013-01-17 | — | — | WO | claimed |
| CN-116606202-A | Preparation method of gallic acid catalyzed by sulfinic acid or sulfonic acid derivative | 云南中倍生物科技有限公司 | 2023-08-18 | — | — | CN | disclosed |
| US-9931355-B2 | Combination of compounds derived from gallic acid for the treatment of cancer | PONTIFICLA UNIVERSIDAD JAVERIANA (CO) | 2018-04-03 | — | — | US | disclosed |
| US-20150313925-A1 | COMBINATION OF COMPOUNDS DERIVED FROM GALLIC ACID FOR THE TREATMENT OF CANCER | PONTIFICIA UNIVERSIDAD JAVERIANA (CO) | 2015-11-05 | — | — | US | disclosed |
| US-7695981-B2 | Seed layers, cap layers, and thin films and methods of making thereof | SILURIA TECHNOLOGIES, INC. (US) | 2010-04-13 | — | — | US | disclosed |
| US-7655081-B2 | Containing aqueous cobalt, tungsten phosphide; reducing agents; metal chelators; for forming cap layer | SILURIA TECHNOLOGIES, INC. (US) | 2010-02-02 | — | — | US | disclosed |
| WO-2008013516-A2 | SEED LAYERS, CAP LAYERS, AND THIN FILMS AND METHODS OF MAKING THEREOF | CAMBRIOS TECHNOLOGIES CORP. (US) | 2008-01-31 | — | — | WO | disclosed |
| US-20060254503-A1 | Seed layers, cap layers, and thin films and methods of making thereof | CAMBRIOS TECHNOLOGIES CORPORATION | 2006-11-16 | — | — | US | disclosed |
| US-20060254504-A1 | Plating bath and surface treatment compositions for thin film deposition | CAMBRIOS TECHNOLOGIES CORPORATION | 2006-11-16 | — | — | US | disclosed |
| US-4109051-A | POLYHYDROXY AROMATIC COATING COMPOSITIONS FOR REINFORCING GLASS FIBERS USED IN CEMENTITIOUS PRODUCTS | PILKINGTON BROTHERS LIMITED (GB) | 1978-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150313925-A1 | COMBINATION OF COMPOUNDS DERIVED FROM GALLIC ACID FOR THE TREATMENT OF CANCER | BAD, BAX, BCL2 | ESR1 2466/4885SERPINE1 1153/4885AKR1C4 2762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.